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EXPLANATION OF THESIS FORMAT 
The thesis has been divided into 3 sections, each of which is to be 
submitted individually for publication. Section is basically a review 
of the literature as a background for the research presented in sections 
I I and I I I. At the beginning of sections I I and I I I is an introduction 
with additional literature review appropriate for the research presented 
in that particular section. At the end of each individual section is a 
summary or discussion of the information and or research presented in 
that section. 
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SECTION l. HYPOTHALAMIC-AOENOHYPOPHYSEAL INFLUENCE ON THYMUS STRUCTURE 
AND FUNCTION 
Introduction 
There is considerable experimental evld_ence of an association 
between the immune system and the endocrine system, more specifically 
the thymus and the endocrine system (12,24,4!,72,97,ll8,). A proper 
balance of hormones at a critical time in development is apparently 
necessary for proper formation and function of the immune system as the 
organism matures and later on in life (39,97). Hormones such as growth 
hormone (GH), thyroxine and cortisol have effects upon the thymus (18) 
and the thymus has effects upon endocrine glands such as the testes, 
adrenal glands (23) and anterior pituitary. For example, thymectomy in 
mice causes degranulation of the acidophils of the anterior hypophysis 
(93), and thymosin fraction 5, an extract of bovine thymus, when 
injected into monkeys causes increases in adrenocorticotrophic hormone, 
cortisol and beta endorphin (64). 
Thymus and Immune Function 
The thymus gland plays an important role in, immune function. It was 
demonstrated in the early 1960s that neonatal thymectomy of mice and 
rabbits led to immune deficiency (57,82). Thymectomized animals had a 
decreased ability to produce antibodies to T-dependent antigens, 
decreased ability to reject skin and tumor transplants, failure to 
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develop normal lymphoid structure in lymph nodes and spleen, and they 
exhibited poor growth and short life span (57,82). The thymus therefore 
is thought to be important in formation of the cellular arm of the 
Immune system. It is important for normal development of the lymph node 
paracortical areas and periarteriolar areas of the sp!enic white pulp 
(Ill). 
The Thymus as an Endocrine Gland 
The experimental evidence which led to the concept of the thymus as 
an endocrine gland has recently been reviewed (58,66). Studies in which 
thymus transplants placed in milllpore filters not permeable to cells 
had a beneficial effect on the development and function of the immune 
system in neonatally thymectomized mice support this concept. The 
demonstration that the injection of thymic extracts into mice would 
partially correct the effects of neonatal thymectomy also gives credence 
to the idea that the thymus exerts at least some of its effects upon the 
immune system through the production and release of chemical mediators. 
Substances shown to influence the development of lymphoid cells have 
subsequently been Identified in serum or extracts of the thymus (58,66). 
Thymosin fraction 5 is an extract of bovine thymus that contains 
many small peptides, some of which have been shown to have an effect 
upon the development and function of lymphoid cells. The function and 
structure of some of the peptides contained in this extract have been 
reviewed by lncefy (66) and Goldstein et al. (56). They are divided 
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into 3 groups, alpha, beta, and gamma, depending upon their isoelectric 
points (56,66). One such peptide, thymosin alpha 1, is made up of 28 
amino acids. An identical peptide has been shown by radioimmunoassay to 
circulate in human blood (66). It Is a strong inducer of helper T-cells 
in mice, and increases the response of murine lymphocytes to mitogens. 
Thymosin alpha 7, another hormone found in thymosin fraction 5, induces 
suppressor T-cells. Another peptide found in the same extract is 
' thymosin beta 4. It contains 43 amino acids and stimulates T-cells at 
an early stage of differentiat.ion, inducing the expression of terminal 
deoxynucleotidyl transferase. Thymosln beta 3, also in fraction 5, is 
' 
very similar to beta 4 in structure and function (56,66). 
Thymopoietin, another extract of bovine thymus, has been identified 
and its amino acids sequenced. It contains 49 amino acid residues, and 
exists in two forms, thymopoietin I and thymopoietin JI, which differ by 
substitution of 2 amino acids. The active component of thymopoietin is 
made of 5 amino acids and has been synthesized in the laboratory. 
Thymopoietin Induces the expression of T-cell alloantigens in the bone 
marrow cells of mice in vitro (66). It also stimulates T-cell functions 
In vivo, for example enhanced rejection of carcinomas in mice (3). 
Human plasma contains substances with activity like that of thymopoietin 
(66). 
Thymic humoral factor (THF), an extract of bovine thymus, was 
isolated and characterized by Tralnin et al. It has been recently 
reviewed by Bach (3) and lncefy (66). THF consists of 30 amino acids 
and causes differentiation and maturation of thymus-derived 
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lymphocytes. It will enhanc~ the mixed lymphocyte reactions of 
lymphocytes from spleen and thymus of intact and thymectomized mice. 
THF also markedly increases the response of human peripheral blood 
lymphocytes to mitogens such as concanavalin A and phytohemagglutinin. 
Therapy with THF in immunodeficient human patients has improved cell 
mediated immunity (3,66). 
Factor thymique serique (FTS) was isolated from the serum of swine 
and characterized by Bach et al. The literature on the structure and 
function of this thymic hormone has recently been reviewed (4). It 
contains 9 amino acids which have been sequenced, and the hormone in the 
serum of swine, humans and catt I e is i dent i ca I . The use of 
immunofluorescence has demonstrated that FTS is produced by epithelial 
cells in the thymus. The fact that an identical compound has been 
isolated from the extract of bovine thymus of Goldstein et al., thymosin 
fraction 5, helps confirm the thymic origin of FTS. The FTS peptide 
chelates zinc which is required for activity. The active form of the 
hormone containing zinc is called thymulin. Thymulin Induces T-cell 
markers on 'spleen eel Is of adult thymectomized mice, normal bone marrow 
cells from mice and humans, nude (athymic} mouse spleen cells, and 
peripheral blood lymphocytes from patients with immunodeficiencies. The 
effect on any given parameter of T-cell function may depend upon the 
dose of thymulin given and the immune status of the subject. For 
example, delayed hypersensitivity to dlnitrofluorobenzene is increased 
in adult thymectomized mice but decreased in normal mice treated with 
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thymulin. The clinical use of thymulin in human patients with 
immunodeficiency diseases has given positive results in some cases (4). 
Hypothalamic-Adenohypophyseal Regulation of Thymus Function 
Hypophysectomy in rats has been shown to cause atrophy of the thymus 
(18,115). Depression of immune responses has also been noted after 
hypophysectomy in mice and rats (11,32,53,90,107). Hypophysectomized 
rats had depressed antibody responses to sheep red blood cells (SRBC) 
(11,32,90) and Escherichia coli lipopolysaccharide (II), slowed 
allograft rejection (32), and decreased DNA synthesis in thymocytes 
(90). These depressed immune reactions could be restored to normal by 
GH (90,124) or prolactin therapy (11,85). According to Berczi et al., 
GH was not as effective as prolactin (11). Treatment of 
hypophysectomized rats with GH but not thyroxine, also caused an 
increase in thymic weight (46). Spleen cell natural killer activity 
against the mouse lymphoma cell line (YAC) tumor cells, and in vitro 
responsiveness of spleen cells to produce antibody to 5RBC was 
suppressed in hypophysectomized mice. These could be restored to normal 
with GH therapy (53,107). Recovery of the ability to produce antibodies 
to SRBC, reject skin allografts and restore leukocyte numbers in 
irradiated adult rats was impaired if they were first hypophysectomized 
(32). Andenohypophyseal hormones therefore may play a role in 
maintenance of thymus and cell mediated immune function in adult life. 
7 
More evidence for the importance of hypophyseal hormones in the 
development of the thymus and cellular immunity is the fact that rabbit 
anti-mouse hypophysis serum caused thymus atrophy when given to young 
mice (93). A wasting disease like that seen with neonatal thymectomy 
was also observed. The anti-mouse hypophysis serum was given at the age 
when thymectomy causes wasting disease in mice (93). Anti-bovine 
somatotrophic hormone (growth hormone) serum (ASTHJ also caused the same 
wasting syndrome in mice (94). Simultaneous treatment with GH prevented 
the disease (94). Rabbit anti-mouse hypophysis serum was shown to bind 
specifically with the acidophils of the anterior pituitary gland. The 
' 
mechanism of action therefore in causing wasting was probably a decrease 
in production or release of GH or perhaps other adenohypophyseal 
hormones (96). Therapy with GH and thyroxine alone or together would 
not prevent wasting in neonatally thymectomized rats, indicating the 
effect of GH in preventing the wasting disease in anti-hypophysis 
treated animals is by its action on the thymus (35). 
Experiments using nude mice have contributed to our knowledge of the 
importance of the hypophyseal hormones in the development of thymus 
function. Nude mice have a congenital, complete lack of a thymus and do 
not reject allogeneic skin grafts. The ability to reject skin grafts 
can be restored with thymic grafts. Thymic grafts however would not 
restore the ability to reject allogeneic skin grafts if anti-hypophysis 
serum was also given (98). 
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Growth hormone has been shown to cause increased uptake of 
radiolabeled metabolites by rat thymocytes in vitro (123,124). Human 
GH in vitro will stimulate proliferation of human peripheral blood 
lymphocytes (73). Mouse spleen cells responded in vitro to GH with the 
generation of cytotoxic T-cells (116). Growth hormone therefore appears 
to have a direct effect on thymocytes and lymphocytes. This effect 
appears to be mediated by specific GH receptors on those cells. 
Receptors have been identified on rat thymocytes (62), human lymphocytes 
(76), and calf and mouse lymphocytes and thymocytes (2). 
The pituitary dwarf mouse has proven to be an excellent model for 
the study of the interaction of the hormones of the anterior pituitary 
and the thymus. The Ames and the Snell-Bagg dwarf mouse are both 
afflicted with a wasting syndrome starting at weaning and have a 
shortened life span (5,28,95). The immune system, especially the cell 
mediated arm, seems to be deficient. The thymus in dwarfs is like that 
of normal mice at 15 days of age, but it is markedly atrophied by 30 
days of age (36). The peripheral lymphocyte count is low (31,36), 
T-cell dependent areas of the peripheral lymph nodes and spleen are 
poorly populated (5,31,36,95,128), and the thymus is small with a 
decreased number of lymphocytes (5,26,28,95). 
Immune function studies in dwarf mice indicate a defect of cell 
mediated immunity. This is manifest as decreased antibody response to 
sheep red blood cells, which are thought to be T-dependent antigens 
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(5,30,31,95). The graft-versus-host reaction of spleen cells from dwarf 
mice is also depressed (31). Dwarf mice have lower plasma levels of the 
thymic hormone (FTSJ than their normal littermates (40,91). 
Pituitary dwarf mice are deficient in GH (28,36,95), thyroxine 
(36,95), prolactin and adrenocortfcotrophic hormone (28). Growth 
hormone therapy alone improved the lymphoid structure of thymus and 
spleen in these pituitary dwarf mice (128). Growth hormone with 
thyroxine also reconstituted the lymphoid tissues including the thymus, 
with a concomitant improvement in the antibody response to T-dependent 
antigens, (SRBC) (6,95) and increased body growth (7). Growth hormone 
and thyroxine therapy also increased the depressed level of serum thymic 
factor (FTSJ to normal (40). In other studies, GH and thyroxine 
together prevented wasting and prolonged life, but the reversal of the 
wasting disease and restoration of the immune system with hormone 
therapy did not occur if the mice were first thymectomize'd · (37,38). 
Treatment of pituitary dwarf mice with lymphocytes from,normal 40 day 
old mice prevented the wasting disease and slowed premature aging 
( 38) • The immune deficiency in 'dwarf m fee therefore appears to be 
caused by a lack of immunocompetent T-cells, because of a thymic 
developmental defect, which in turn is caused by deficiency of GH and 
possibly other pituitary hormones. Prolonged nursing or intraperitoneal 
injections of mouse milk in Snell and Ames dwarf mice also prevented the 
T-cell depletion, lymphopenia, thymfc atrophy and depressed response to 
sheep red blood cells (27,29). The factor in milk that restores 
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invnunity in dwarf mice may be a pituitary hormone such as GH or 
prolactfn. 
A sex-linked dwarfism has been reported in chickens in which there 
is invnunodeficiency. Treatment with GH increased humoral invnunity and 
the size of the bursa of Fabricius. Therapy with thyroxine caused an 
increase in the size of the thymus (80). 
Reports of human infants with panhypopituitarism and recurrent 
infectious d.iseases have been noted (67,114). Two of these were 
reported to have a small thymus or total lack of a thymus at autopsy 
(114,120). One baby was noted to have a small thymus and poor Immune 
function. She had been maintained on cortisol and thyroxine therapy but 
did not show an improvement in lmmunocompetence untl·l GH was added 
(13). Children with isolated GH deficiency have been noted to have 
T-cells that respond poorly in allogeneic mixed lymphocyte reactions 
(MLRJ and non-T cells that are poor stimulators of MLR. They were also 
noted to have increased proportional numbers of OKT8+ 
(suppressor-cytotoxic) T-cells and B-cells (59). 
Immunodeficient dwarfism has been reported in Weimaraner puppies 
(105). These puppies were afflicted with a wasting syndrome which began 
after weaning. There was severe hypoplasia of the thymus, but 
T-dependent areas of lymph nodes and peripheral lymphocyte counts were 
normal. There was a depression of the response of peripheral 
lymphocytes to phytohemagglutinin (PHAJ. They were confirmed to be 
GH deficient by measuring GH by radiofmmunoassay before and after 
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clonidine stimulation. Administration of thymosin fraction five 
eliminated the wasting disease but did not restore the thymus to normal 
or improve the response of lymphocytes to PHA (105). Therapy with GH 
however did normalize the thymus and prevent the wasting syndrome (106). 
The hypothalamus-adenohypophysis also affects the thymus through 
adrenocorticotrophic hormone (ACTH) and the adrenocortical hormones. 
The increase in cortisol associated with stress in humans causes severe 
atrophy of the thymus with reduction of lymphocyte numbers within 2 to 3 
days, followed by regeneration within 8 to 10 .days of the stressful 
event (14). Rats treated with ACTH or cortisone had severe destruction 
of their thymuses with many thymocytes destroyed within 48 hours (129). 
The elements of the thymus were decreased similar to that seen with old 
age atrophy, such that no differentiation between cortex and medulla 
could be made. Adrenalectomy on the other hand caused an increase in 
the size and cellularlty of the thymlc cortex and medulla (129). In 
rats, stress causes a decrease in GH (102). Dogs and humans with 
hyperadrenocorticism have decreased release of GH in response to normal 
stimulators of GH release. The response returns to normal when the 
hypercortisolemla is corrected (84,92,121). Corticosteroid therapy in 
humans also causes a lack of GH response to normal stimulators of 
release (50). A lack of the trophic effect of GH may then be at least 
partially responsible for the thymic atrophy associated with stress and 
increased adrenocortical hormones. In certain types of stress in 
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people however, plasma GH is increased (1,21). This increase in GH may 
then be a response to counteract the effects of cortisol as demonstrated 
in hypophysectomized mice in which GH restored immunity and prevented 
the lmmunosuppressive effects of cortlcosterone (53). 
Aging and Thymus Involution 
Part of normal aging Is deterioration of Immune function. This is 
evidenced by a decreased ability of mice and humans to produce 
antibodies to T-dependent antigens (20,54,103,130). Depression of 
T-helper activity and an Increase in T-suppressor activity may be 
responsible for this decline in antibody formation (20,54,103). Aging 
in humans has been associated with a decreased ability to mount delayed 
type hypersensitivity reactions to antigens which normally cause such a 
reaction (103). The response of lymphocytes in vitro to mitogens such 
as phytohemagglutinin (PHAJ is significantly decreased in aged humans 
and dogs when compared to younger controls (52,72,103). The ability of 
mice to resist challenge with syngeneic and allogeneic tumor cells in 
vivo also declines with age (79). All of this evidence then points to 
an age associated decline In immune function. Decreasing immune 
function has been associated with an increase in the incidence of 
autoimmunity and neoplasia In aged individuals (71). 
The thymus peaks in size and activity at puberty or young adulthood 
and progressively declines with advancing age (72,88,113,126). In dogs, 
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there is a significant correlation between age and the number of 
lymphocytes in the thymus (88). Studies in humans have also shown that 
the thymic cortex involutes with age with a decrease in the number of 
lymphocytes (72,113). This decrease in thymic cortical size appears, at 
1 east in humans, to fa 11 ow an exponent i a 1 curve (126) • 
It is a popular belief that the age-related decline in immune 
function is closely associated with or perhaps caused by thymic 
involution (41,71,72,131). Plasma thymic hormone levels have been shown 
to decrease with age along with atrophy and involution of the thymus 
(55,77). Thymosin fraction 5, an extract of bovine thymus, has been 
shown in vitro to enhance the mixed lymphocyte reaction (MLR) of 
peripheral lymphocytes from aged and young humans. Lymphocytes from the 
aged individuals had lower mixed lymphocyte reactions than lymphocytes 
from the young individuals before treatment, but the reactions were 
equivalent for both groups after treatment (19). Thymosin alpha 1 in 
aged mice in vivo will restore helper T-cell activity and increase 
antigen specific T-cell dependent proliferation of lymphocytes (51). 
The fact that thymic hormone levels decrease with age and have been 
shown to restore some of the impaired cellular immune functions that 
also decline with age implies that a decline in the production of thymic 
hormones by an involuting thymus gland is at least partially responsible 
for immunologic senescence (41,72). 
As the thymus and the cell mediated immune system involute with 
age, GH secretion also declines. In aged men, the amplitudes of sleep 
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related GH peaks are significantly reduced when compared to young 
controls (8,15,99,117). Growth hormone release, in response to normal 
stimulators of its release is also reduced in aged men (8). Mean 24 
hour plasma GH levels are reduced in older men as compared to young men 
in some reports (8,47,81), but not in others (99). Some authors 
indicate baseline GH levels in rats decrease with age (25), but others 
indicate they do not (49). In dogs, plasma GH levels are significantly 
higher in puppies than In adults (127). 
Growth hormone then has a definite role In normal thymlc and cell 
mediated immune system development and function. This has been shown to 
be important in young developing animals; GH and thyroxine therapy 
prolonged life in Immunodeficient dwarf mice (37,38). Endocrine 
Influence on the Immune system in adulthood also appears to be 
important; hypophysectomy of adult rats Inhibited recovery of cell 
mediated Immunity after irradiation (32). Thymlc Involution and immune 
senescence then may be due to or controlled by a concomitant reduction 
in GH secretion. Other authors have suggested this association between 
immune senescence and endocrine homeostasis (39,71). 
The thymus appears to continue to have an effect upon immune 
function in adult life as indicated by adult mice showing a decrease in 
graft versus host reactions when thymectomlzed In adulthood (125). 
Administration of GH to adult animals then may stimulate thymus function 
and prevent or reverse senescence of the cell mediated immune system and 
Improve health In old age. This hypothesis has been tested in adult 
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dogs using bovine growth hormone (83a). The thymus was biopsied via 
thoracotomy prior to therapy to determine that it was atrophied. Bovine 
growth hormone was administered subcutaneously in 14 doses over a 28 day 
period. Two weeks after the last dose the dogs were euthanatized and a 
necropsy performed. All of the GH treated dogs responded well with a 
marked increase in numbers of lymphocytes in the thymus with obvious 
cortex and medulla compared to pretreatment thymus in which no 
distinction could be made between cortex and medulla in most of the 
dogs. This then indicates that GH may be useful in preventing or 
reversing the senescence of the cell mediated immune system. 
Summary 
The endocrine system then is integrally involved in normal 
development, function and aging of the immune system. This has been 
shown experimentally by hypophysectomy, the use of antihypophysis serum, 
and the demonstration of GH receptors on lymphocytes and thymocytes. 
Natura 1 mode 1 s such as the i mmunodefi c.i ent pituitary dwarf mouse, 
pituitary dwarf human patients, immunodeficient dogs with isolated GH 
deficiency, and immunodeficient dwarf chickens have contributed greatly 
to the Idea of neuroendocrine regulation of immune function. The key to 
immune senescence and aging may involve an imbalance or deficit of one 
o·r many hormones inc 1 ud i ng GH, pro 1 act in, thyroxine and other 
hypophyseal products. Further research is needed to assess the ability 
of these hormones to restore the aged or deranged immune system, and to 
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evaluate immune function in patients with endocrinopathies. Compounds 
which stimulate the release of these hormones should also be tested for 
their ability to affect immune function. The use of hormones 
therapeutically then may also prove useful for treating disease, 
restoring immune function, and the prevention or reversal of aging. 
The discovery and characterization of the structure and function 
of the thymic hormones also has improved understanding of the function 
and regulation of the immune system. The clinical use of these hormones 
in primary and secondary immunodeficiencies, autoimmune disease, 
neopfasia, and virus and fungal infections may prove to be of 
considerable benefit to medicine and the overall health and longevity of 
animals and man. They may also prove useful as a measure of thymic or 
cell mediated immune function in a variety of pathologic and physiologic 
conditions. 
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SECTION II. THE EFFECTS OF GROWTH HORMONE ON THE ADULT CANINE THYMUS 
Introduction 
The thymus is known to be very important In the development of the 
cell mediated immune system (Ill). This was shown dramatically by Good 
et al. and Miller when they observed the effects of thymectomy on mice 
and rabbits (57,82). The thymus normally lnvolutes with advancing age 
in most mammals including man (113) and the dog (88), beginning shortly 
after puberty. 
The proper function of the immune system, especially T-cell 
function, wanes with age (130). Depressed ability to mount delayed type 
hypersensitivity reactions, decreased responses to T-dependent antigens 
and lesser ability of lymphocytes to undergo mixed lymphocyte reactions 
and respond to mitogens in vitro all occur with aging (19,20,103). 
Thymic involution is thought to play a pivotal role in this immune 
senescence (71,79). In older humans, the levels in plasma of some 
thymic hormones are reduced (55,77), and administration of thymic 
hormones improves some age associated T-cell deficiencies (19,51). 
Thymlc Involution then is Important in the decline of immune function 
with aging which is perhaps mediated by a decrease in thymic hormone 
production. 
Growth hormone (GHJ appears to have an effect upon the normal 
development and function of the immune system, particularly the thymus 
and cellular irrrnunity. Pituitary dwarf mice are GH deficient and have 
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severe deficiencies in cellular immunity including decreased peripheral 
lymphocyte counts, depletion of T-dependent areas of lymph nodes and 
severe early atrophy of the thymus (5,29). These defects can be 
restored to normal by therapy with GH (5). Dwarfs with immunodeficiency 
that could be significantly improved with GH therapy have also been 
reported in humans (13) and dogs (106). 
Further evidence for a role of the hypophysis and growth hormone 
(somatotrophic hormone) .in cellular immunity is provided by the use of 
anti-somatotrophic hormone serum (ASTH) in mice. This serum caused the 
same immunodeficiency and wasting syndrome as that seen in dwarf mice, 
and could be prevented by administration of GH (94). Growth hormone 
therapy however could not prevent immunodeficiency when ASTH-treated 
rats were also thymectomized as neonates (35). This Indicates the 
effect of GH in preventing the immunodeficiency in ASTH-treated animals 
is through its action on the thymus. 
The concentration of GH in plasma of men has been shown to decrease 
with advancing age (8,47,81), especially the sleep related peaks of GH 
secretion (8,99,117). Plasma growth hormone in dogs is also 
significantly less in adults than in puppies (127). 
Because GH has a definite effect on thymic development in young 
animals and plasma levels decline with age along with an involution of 
the thymus and the cell mediated immune system, it is hypothesized that 
this decrease in GH secretion is at least partially responsible for 
thymic involution. Administration of GH then to adult or aged animals 
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may prevent thymic involution or restore an involuted thymus and 
declining invnune function to normal. Growth hormone therapy has been 
tested in old men and rats, however invnune function and thymic 
morphology were not studied (34,104). The purpose of this experiment 
was to test the hypothes'is that GH treatment of adult dogs with age 
atrophied thymuses would cause regeneration of the thymus gland, and 
thereby reverse the age associated decline in cell mediated immunity. 
Materials and Methods 
Animals 
Eight young adult dogs (estimated to be approximately 2-5 years old) 
were obtained from the laboratory animal resources unit of the College 
of Veterinary Medicine, Iowa State University. Two dogs of known age 
and breeding were obtained from a commercial kennel, one 4.5 year old 
West Highland White Terrier female (dog 15) and one 3.5 year old 
Miniature Schnauzer female (dog 16). All dogs were evaluated by 
physical exam, complete blood count, urinalysis, fecal flotation for 
parasite ova, filtration test for heartworm microfilariae and serum 
chemistries including glucose, alanine transaminase, alkaline 
phosphatase, calcium, phosphorus, sodium, potassium, urea nitrogen, and 
albumin. Blood was also obtained for lymphocyte blast transformation 
(LBT) studies in response to non-specific mitogens performed as 
previously described (105,106). If fecal flotation was positive, the 
dogs were treated with pyrantel pamoate or dichlorvos depending upon the 
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parasite present, and a subsequent fecal flotation was performed to 
assure therapy was adequate. 
Experimental design 
If the dogs were found to be healthy, a thoracotomy was performed to 
obtain a biopsy of the thymus gland for histologic evaluation. If the 
biopsy results indicated thymus tissµe was present and involuted, 5 dogs 
were randomly chosen to be treated with bovine serum albumin (BSA) 
(Sigma Chemical Co., St. Louis, Mo.), and 5 dogs were treated with 
pituitary derived bovine growth hormone (BGH) (Monsanto Co., St. Louis, 
Mo., Lot No. m-34-12162) at a dosage of 0.1 mg./kg. of body weight given 
subcutaneously daily for 5 doses, then every other day for 5 doses and 
then every third day for 4 doses. 
days to 3 weeks after thoracotomy. 
Therapy was begun approximately 10 
A complete blood count and LBT were 
performed weekly on blood from each dog. Eight to 9 weeks after 
thoracotomy, and 2 weeks after the last dose of BGH or BSA, the dogs 
were euthanatfzed with sodium pentobarbitof intravenously and 
necropsied. Thymus was again evaluated histologically and all other 
major organs and all other endocrine glands evaluated for pathologic 
lesions. 
Results 
Thymic histology in BGH treated dogs (Table l) 
All dogs prior to therapy had moderately to severely atrophied 
thymus glands on hlstologic examination. They were characterized by 
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multiple small nodules of thymus consisting of small lymphocytes, 
epithelial cells, Hassall's corpuscles, blood vessels, and cysts lined 
by c i l iated ce l l s • In general , a di st i net ion between cortex and medu l la 
could not be made. 
After BGH treatment, all 5 treated dogs had a regenerated thymus 
gland. The glands consisted of many lobules of thymus within a delicate 
stroma of adipose tissue. There was a dense population of small, mature 
and in some cases larger more immature lymphocytes in the cortex. 
Approximately 51. of the cortical cells were large epithelial cells. A 
clear distinction between cortex and medulla could be made and the 
cortex was generally larger than before treatment. The meduliary areas 
contained small lymphocytes and some had large lymphoblasts as well. 
There were epithelial cells and Hassall's corpuscles present. Some of 
the glands contained low numbers of eosinophils and some contained 
germinal centers, generally at the cortico-medullary junction 
(Figure l). 
Thymic histology in BSA control dogs (Table l) 
Prior to therapy, the 5 BSA treated dogs had thymuses similar to 
those of the BGH treated dogs before treatment. After the 
administration of BSA, the thymus glands of the control dogs had not 
regenerated as consistently or as markedly as the BGH treated dogs. 
Dogs 11 and 19 did however have marked regeneration of the thymus 
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similar to the dogs that were injected with BGH. Dog l3 had an increase 
in germinal centers, but did not show the typical growth in lobules and 
expression or a cortex and medulla or the growth hormone treated 
dogs. The thymus or dog 15 had a very slight increase in lymphocytes, 
and that or dog 18 showed only a very mild increase in lymphocytes and 
cortico-medullary distinction (Figure 2). 
Table 1 
Summary or histologic responses or thymuses or BGH and BSA treated dogs 
Dog # Breed Sex Weight Kg. Trmt. Histologic R~sponse or Thymus 
4 Poodle F 3.0 BGH Marked regeneration 
5 Mix M 3.2 BGH Marked reger:ieration 
9 Mix M 4.8 BGH Marked regeneration 
10 Mix F 3.0 BGH Marked regeneration 
16 Schnauzer F 6.0 BGH Marked to moderate regeneration 
11 Shep mix M 24.5 BSA Marked regeneration 
13 Mix F 9. I BSA Slight change, germinal centers 
15 Westie F 8.2 BSA SI i ght change 
18 Mix F 6.4 BSA Mild regeneration 
19 Mix M 7.0 BSA Marked regeneration 
Lymphocyte blastogenesis studies 
There were no consistent changes or trends in the response or 
peripheral lymphocytes to mitogens in vitro in the BGH or BSA treated 
Figure !. Hfstologfc sections, BGH treated dogs, 17.6 X 

,- . 
Figure 2. Hi,stologic sections, BSA treated controls, 17.6 X 
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dogs. There was marked variability of the response between dogs and 
within the same dog from week to week (data not shown). 
The variability in the response of lymphocytes from the dogs in this 
study to non-specific mitogens is consistent with other reports of 
variability and inconsistency of the lymphocyte blastogenesis assay 
(75a,106J. There was variability in the response of the lymphocytes 
from individual dogs from day to day, and variability among dogs on any 
given day. There was no reliable trend or change in the responsiveness 
of cells from the BGH treated dogs or the BSA treated control dogs. The 
lymphocyte blastogenesis assay therefore was not helpful in this study 
in determining the effects of growth hormone therapy on eel I-mediated 
immune function. 
Total white blood eel l and lymphocyte counts 
Total white blood cell counts in the BGH treated and BSA treated 
controls changed minimally from week to week, and there were no 
consistent trends of increasing or decreasing numbers. Likewise, 
lymphocyte numbers showed minimal variability between treatment groups, 
or week to week for individuals. There were no consistent changes in 
dogs from either group (data not shown). 
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Discussion 
The GH treated dogs of this study regenerated thymus more 
consistently and markedly than the BSA treated control dogs, however, 
two of the controls responded Just as well. Because of the unexpected 
positive response in some of the controls, one cannot conclude that 
growth hormone was the only factor stimulating thymic regeneration In 
these dogs. One can conclude that administration of growth hormone to 
adu'lt dogs wi 11 cause or contribute to thymic regeneration. A decrease 
in growth hormone, therefore, along with many other factors may play a 
role in thymic involution and Immune senescence. 
The fact that the thymuses of some of the control dogs showed marked 
regeneration after surgery and BSA administration brings up many 
questions about the hormonal interactions with the immune system. The 
control dogs may have been exhibiting "accidental atrophy" induced by 
stress related increases in cortisol (14) when the thymus was first 
biopsied. In humans with accidental thymic atrophy there is severe 
reduction of thymic lymphoc:Ytes within 2 to 3 days of cortisol 
administration or a stressful event, and the thymus returns to normal 
within 8 to 10 days (14). Treatment of rats with ACTH or cortisol 
causes severe destruction of the thymus with destruction of thymic 
J'ymphocytes (129). Adrenalectomy however, was shown to cause an 
Increase in the cellularity and size of the thymic medulla and cortex 
(129). In rats, stress has been shown to cause a decrease in GH (102). 
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In dogs and humans with hyperadrenocorticism, the release of GH in 
response to compounds which normally stimulate GH release is decreased 
' 
(84,92,121). Corticosteroid therapy In humans also causes loss of 
normal GH release in response to stlmulators (50). Thymic atrophy 
associated with increased adrenocortical hormones and stress may· then be 
at least partially caused by a lack of the t~ophic effect of GH. Rebound 
rele~se of endogenous GH may then be Involved in thymic regeneration 
after atrophy due to stress. In humans, GH increases with stress 
(1,21), which may then counteract the effects of cortisol as shown in 
hypophysectomized mice in which GH prevented the immunosuppressive 
effects of cortlcosterone and restored Immunity (53). The thymuses In 
the two control dogs that showed regeneration may have been atrophied 
due to stress and depressed GH release at the time of first biopsy. 
Subsequent rebound release of GH may then have caused the regeneration. 
Age may be an important factor concerning the ability of the thymus to 
regenerate after stress Involution. Young men and dogs have higher 
plasma GH level_s than aged men and dogs (8,47,81,127), and therefore may 
be able to release greater amounts of the hormone In response to stress 
induced atrophy of the thymus. 
The effect of surgical manipulation upon a normally involuted thymus 
must also be considered. Manipulation of thymic tissue and adhesions 
which occurred in virtually all dogs in the study may have played a role 
in thymic regeneration in both the control and GH treated dogs. Perhaps 
inflammation with macrophage infiltration and release of monokines may 
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have stimulated the thymus. The stress of surgery may have stimulated 
release of endogenous GH which then caused the response. Wound healing 
may require endogenous GH release, Implied by studies·in rats in which 
GH therapy improved wound healing (74,100). Release of endogenous GH to 
promote wound healing may then have also stimulated thymic regeneration 
in the control dogs after surgery. 
The question of what controls thymlc Involution then becomes very 
co~plex. Age related changes in the relative balance of many hormones 
may be Involved in thymic involution and immune senescence (39). 
Immunodeficient dwarf mice are deficient not only in GH but also ACTH, 
TSH, thyroxine, and prolactln (28,36). Growth hormone and thyroxine 
together did a better job of restoring the lymphoid organs and immune 
reactivity fn these mice than GH alone (6,7). Balb/c mice show a 
decrease in thyroxine with age along with age associated depression of 
immune responsiveness. Therapy of these animals with thyroxine 
increased serum thymlc factor levels and T-cell responses to PHA (42). 
Studies in rats have shown a relationship between prolactin and 
ce.llular Immunity. In one study, prolactln was more effective than GH 
In restoring immunity In hypophysectomized rats (11). Other studies 
indicate prolactin, GH and human placental lactogen were equally capable 
of restoring immune function in hypophysectomized rats (85). 
The immunodeficient pituitary dwarf dogs described by Roth et al. 
(105,106) appear to have isolated GH deficiency (83). Human and other 
canine cases of isolated GH deficiency however, have been reported 
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and apparently occur without impairment of immune function (87,109). 
The sex steroids also appear to have an effect upon the immune 
system. Thymic cortical involution in women follows a biphasic curve, 
with an increase in thymic size just prior to menopause (112). 
Testosterone has been shown to decrease the plaque forming cell response 
of mice to sheep red blood cells (24). 
The ability of thymus to respond to the various hormones that affect 
lymphoid function also decreases with age. In aged rats, the number of 
thymocytes with GH receptors is significantly lower than in young rats 
(62,122). The responsiveness of rat thymocytes Incubated in vitro with 
GH also decreases with age (123). 
Inhibition of GH and other pituitary hormones action or production 
and release may occur due to inhibitory substances produced by the 
hypophysls. This Is implied in a study using middle-aged mice in which 
simultaneous hypophysectomy and replacement therapy with cortisol, 
thyroxine and GH caused thymic regeneration when compared to age-matched 
controls (63). The timing of hormone therapy may also affect the type 
of response obta.i ned ( 119) • 
The cause for thymic involution and senescence of the cell mediated 
imlilune system is therefore probably very complex, involving the 
interaction of many hormones and chemical mediators. The study reported 
here does seem to indicate GH is involved In this Involution process and 
that therapy with GH will at least play a role in stimulating thymic 
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regeneration in adult dogs. The use of dogs of known age and breeding, 
and a means of evaluating thymic size and function without surgery would 
improve ones ability to evaluate the. effects of various hormones upon 
the thymus. Thymic hormones may prove useful for this purpose. 
Evaluation of the effects of hormones such as prolactin, thyroxine, 
somatostatin, somatomedins and growth hormone alone or in combinations 
may provide useful Information on how to restore the aged immune system. 
Examination of hormone levels such as .GH, thyroxine and prolactin after 
surgery may provide insight into why some of the co~trol dogs also 
responded. This would help explain the apparent association between the 
endocrine system, thymic involution and Immune senescence. 
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SECTION III. EVALUATION OF ENDOCRINE FUNCTION IN PUPPIES FROM 
IMMUNODEFICIENT DWARF PARENTS 
Introduction 
Immunodeficient dwarfism has been described in Weimaraner dogs by 
Roth et al. (105). All of the dogs in this colony are affected with 
dwarfism and have lymphocytes which respond poorly to non-specific 
mitogens in vitro. These dogs have normal baseline levels of growth 
hormone (GH) but lack a normal response to compounds which stimulate 
GH release in normal dogs. At weaning, some of the puppies develop a 
wasting disease with poor growth, recurrent infections and death. The 
puppies with wasting syndrome have atrophied or hypoplastic thymus 
glands. Treatment of these puppies with thymosin fraction 5, an extract 
of bovine thymus, caused marked clinical improvement in the wasting 
disease, but had no effect on thymus morphology (105). Growth hormone 
therapy however not only prevented the wasting disease, but also caused 
the thymus gland to regenerate to normal (106). 
In puppies, it has been established that GH has an effect upon the 
development of normal thymic size and activity (105,106). Because 
other pituitary hormones have been shown to have an effect upon the 
thymus and other lymphoid tissues In other species (6,14,18,95,129), 
puppies from Immunodeficient dwarf parents were evaluated for thyroid 
and adrenal cortical function and for GH. 
Radioimmunoassay procedures for measuring plasma GH in the dog have 
been shown to be sensitive and repeatable (33,60,127). Because 
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baseline levels of GH in plasma are low, provocative tests are required 
to evaluate pituitary secretion. Clonidine has been shown to be 
reliable for stimulation of GH release, and therefore for evaluation of 
this aspect of pituitary function in the dog (61,109,127). 
The thyroid stimulating hormone (TSHJ response test has been shown 
to be a useful test for evaluation of thyroid gland function 
(9,65,69,70,78,89). Patients with a pituitary deficiency of TSH have a 
depressed response to exogenous TSH administration (10,86,110). Dogs 
with normal pituitary TSH production have a normal response to exogenous 
TSH administration. The TSH response test was therefore used in this 
study to evaluate TSH production indirectly. Measurement of plasma TSH 
in the dog with the use of a human TSH specific radioimmunoassay 
procedure has not proven useful for the evaluation of thyroid (16,75b) 
or pituitary function (75b). 
For evaluation of adrenal cortical function in the dog, the use of 
exogenous adrenocorticotrophf c hormone (ACTH) has proven to be useful 
(17,43,68,108). Dogs with hypopituitarism, and therefore lacking ACTH 
would be expected to show little increased release of cortisol in 
response to exogenous ACTH administration due to atrophy of the adrenal 
cortex (86,109). The measurement of plasma ACTH in the dog is possible, 
however there is considerable overlap of the range of values in normal 
dogs and dogs with endocrine dysfunction (44,45). The ACTH response 
test was used in the puppies in this study in order to indirectly 
evaluate pituitary function in terms of ACTH production. 
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Materials and Methods 
Animals 
Two litters of 3 puppies each, 6 months of age, born to 
immunodeficient dwarf Weimaraner parents were the subjects of the study. 
Litter 21 was the offspring of dogs I and 3, and litter 23 was the 
offspring of dogs I and 6 described previously by Roth et al. Dog I had 
been affected by the wasting disease described therein and dogs 3 and 6 
(females) had not been affected with wasting, but were siblings of dog I 
and lacked the normal release of GH In response to clonidine 
administration (105). The puppies in the present study were not 
apparently affected with the wasting syndrome, but were smaller than 
normal for the breed and considered to be dwarfs. Three puppies in a 
litter (litter 24) born to normal mixed breed parents were used as 
controls for the growth hormone evaluation. 
Clonldine stimulation and determination of growth hormone 
Clonidine was used to stimulate GH release. Two baseline blood 
samples were drawn, then clonidine hydrochloride (Boehringer Jngelheim 
Ltd., Elmsford, New York, supplied by Dr. E. Socolow and Dr. S. Garbus) 
was injected JV at a dosage of 16.5 ug./kg. of body weight. Additional 
blood samples were taken at post-injection minutes 15, 30, and 60. All 
samples were collected in heparlnized tubes and placed immediately into 
an ice bath. Plasma was separated by centrifugation at 4 C and frozen 
at -70 C. The samples were then packed in dry ice and shipped frozen to 
36 
the New York University Medical Center for performance of the canine GH 
specific radioimmunoassay which has been validated in the dog (60). The 
upper and lower limits of the assay were 30 ng./ml. and 1 ng./ml. 
respectively. For purposes of statistical calculations, plasma samples 
with undetectable levels of growth hormone were assigned a value of I, 
and samples with levels above the upper limits of the assay were 
assigned a value of 30. A t~test was used to determine the significance 
of differences between experimental and control dogs. 
TSH response test 
The puppies were fasted for 12 hours prior to testing. A resting 
blood sample was drawn. Ten units of TSH (Dermathycin, Burroughs 
Wellcome Co., Kansas City, Missouri) was then given IV and a second 
sample was drawn 8 hours later. The samples were allowed to clot and 
serum separated by centrifugation and sent to a commercial laboratory 
(SmithKline Clinical Laboratories, Inc., St. Louis, Missouri) for 
analysis by radioimmunoassay for T4. Reference values for T4 in the dog 
were estab 1 i shed by the 1 aboratory at 1. 2 to 4. 2 ug. /d 1. for resting 
samples. Radioimmunoassays developed for use In humans have been 
validated for T4 in canine serum (101). 
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ACTH response test 
After.a 12 hour fast, a resting blood sample was taken from each 
puppy. ACTH (Adrenamone, Burns-Biotec Laboratories, Inc., Omaha, 
Nebraska) was then given IM at a dosage of 1 !U./lb. and a second blood 
sample was taken 2 hours later. All blood samples were drawn into EbTA 
tubes and centrifuged to separate the plasma. Samples were sent out to 
a laboratory for analysis of canine cortisol by a radioimmunoassay 
technique which has been validated In the dog (V. K. Ganjam, University 
of Missouri College of Veterinary Medicine, Columbia, Missouri). 
Results 
Growth hormone 
The results of growth hormone assays are summarized in Table 1. A 
t-test for two sample means indicated growth hormone levels in the 
experimental dogs were significantly lower than in the control dogs at 
15 (P <0.01), 30 (P <0.01), and 60 (P <0.01) minutes post-clonidine 
injection. 
TSH response test 
The results of thyroid hormone assays are summarized in Table 2. 
Resting levels and post-TSH responses were normal for all puppies. 
Normal resting values were provided by the laboratory (1.2 to 4.2 
ug./dl.J. Two times the baseline value or greater than 4 ug./dl. was 
considered to be the normal response to TSH (9,65,69,70,78,89). 
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Table 1 
Growth Hormone Concentration in Plasma ng./ml. 
Immunodeffcient Dwarf Dogs 
Dog # 0 Min. 0 Min. 15 Min. 30 Min. 60 Min. 
21-2 1. 7 1 • 6 13.9 14.4 1.8 
21-6 5.2 5.8 28.2 28.6 6.7 
21-3 1 0. 1 6.8 14.0 15. 1 4.0 
23-1 4.9 7.2 22.3 25. 1 7.9 
23-3 10.5 10.2 16.5 15.5 7.6 
23-5 8.8 6.0 23. 0 . 23.6 4.7 
Mean 6.87 6.27 19.65 20.38 5.45 
SEM 1.42 1. 14 2.35 2.50 0.97 
Normal Control Dogs 
Dog # 0 Min. 0 Min. 15 Min. 30 Min. 60 Min. 
24-1 18.6 11.8 >30.0 >30.0 22.6 
24-2 1.5 I • 4 29.2 >30.0 20.7 
24-3 < 1.0 < 1.0 >30.0 >30.0 19.5 
Mean 7.03 4.73 29.73 30.0 20.93 
SEM 5.79 3.54 0.27 0.0 0.90 
Upper and lower 1 i m its of assay, 30.0 and 1.0 ng./ml. 
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Table 2 
Thyroxine, T4 in Serum, Resting and Post-TSH, ug./dl. 
Dog # 0 hour 
21 .2 1.6 
21.3 1.8 
21.6 1.6 
23. 1 2.0 
23.3 1. 9 
23.5 2.8 
Normal levels, 1.2 to 4.2 resting, over 4.0 E!OSt-TSH 
Table 3 
Plasma Cortisol, Resting and Post-ACTH, ug./dl. 
Dog # 0 Hour 
21-2 1 • 5 
21-3 1.8 
21-6 2.5 
23-1 1.4 
23-3 2.4 
23-5 2. 1 
Normal levels, 0.5 to 2.5 resting, 11.0 to 20.0 E!OSt-ACTH 
8 hours 
6.4 
7.7 
7.6 
7.9 
7.5 
7.2 
2 Hours 
13. 1 
1 1 • 2 
1 1 • 3 
13.9 
13. 1 
12. I 
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ACTH response test 
The results of cortisol hormone assays are summarized in Table 3. 
Resting values and post-ACTH respones were normal for all puppies. 
Normal values were provided by the laboratory (0.5 to 2.5 ug./dl. 
resting, 11.0 to 20.0 ug./dl. post ACTH). 
Discussion 
There has been a great deal of experimental evidence which indicates 
there is a close association between the· immune system and the endocrine 
system (12,18,24,41,72,97,118). Immunodeficient dwarf dogs which have 
severe thymic hypoplasia or atrophy and develop a wasting syndrome at 
weaning have been shown to be GH deficient (105). Therapy with GH in 
puppies affected with the wasting disease causes clinical improvement 
and regeneration of the thymus (106). This is similar to 
Immunodeficient dwarfism in mice which have thymus atrophy, lack of 
lymphoid development, poor cell mediated immunity and develop a wasting 
syndrome that leads to early death. Treatment of these mice with GH 
improves immune function and restores lymphoid tissues to normal (118). 
In pituitary dwarfism, GH is deficient, and TSH and ACTH may be 
deficient as well ( 109, 110). Evaluation of pituitary dwarfs for TSH and 
ACTH function is then also important. With prolonged deficiency of TSH 
and ACTH, the target glands of these hormones atrophy and will not 
respond normally to stimulation (10,86,109,110). The puppies in this 
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study had normal responses to TSH and ACTH and therefore probably 
produce normal amounts of these hormones. When compared to normal mixed 
breed control puppies, the puppies of this study from immunodeficient 
dwarf parents had significantly less release of GH in response to 
clonidine administration. Immunodeficient dwarfism in Weimaraner dogs 
then appears to be an isolated GH deficiency, however prolactin and the 
gonadotrophic hormones were not evaluated. This deficiency may be a 
lack of production of GH or an inability of the adenohypophysis to 
release it in response to clonfdine. 
All of the dogs in the immunodeficient dwarf colony are deficient in 
cell mediated immunity, but only some of them develop the wasting 
disease with severe thymic atrophy or hypoplasia. All of the dogs, 
however, fail to respond normally to clonidine administration with 
release of GH demonstrated In this study and that of Roth et al. 
(105). There may be a threshold level of GH production required to 
prevent wasting disease. The puppies which develop the wasting syndrome 
then may produce even· less GH than the non-wasting, but yet GH and 
immune deficient puppies. 
Puppies thymectomized at birth do not show any appreciable 
depression of cell mediated immunity or alterations of lymphoid 
structure (48). Thymectomy of 48 day old dog fetuses however caused 
depression of the ability to reject allografts and decreased blood 
lymphocytes at 24 hours and 3 to 5 months of age respectively (22). 
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Hormone levels in utero then may be important in normal development of 
the thymus and cell mediated immune system. Maternally derived hormones 
such as GH or prolactin may be affecting this development. Growth 
hormone deficient puppies which become affected with wasting after birth 
may have been. in a pas it ion in utero where they were deprived of 
maternally derived hormones, as opposed to GH deficient puppies which do 
not develop wasting after birth. 
Immunodeficient dwarf puppies that develop wasting, versus puppies 
that do not develop wasting may be deficient in other hormones not 
assayed in the present study. Hypophysectomy in rats led to depression 
of cell-mediated immunity which was improved toward normal more 
effectively by prolactin therapy than by GH therapy (II). The 
immunodeficient dwarf puppies that develop wasting may then be deficient 
in prolactin as 'Well as GH and a combined defect in the production of 
these two hormones may then be necessary to cause the wasting syndrome. 
Replacement of one of these hormones, GH, may be enough to prevent the 
disease as demonstrated by Roth et al. (106). A lack of somatomedin 
activity in the puppies that develop wasting as compared to puppies that 
do not show wasting may also be involved. 
The hypothalamic~adenohypophyseal defect in immunodeficient dwarf 
dogs then appears to be a deficiency in GH but not TSH or ACTH, at least 
in the dogs which do not develop the wasting syndrome. The reason why 
some immunodeficient dwarf puppies develop wasting disease and some do 
not is unknown. Wasting that develops after weaning may be brought 
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about by in utero events that affect thymic development or deficiencies 
of other hormones besides GH. 
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SUMMARY 
The endocrine system and the Immune system are Interdependent. 
Normal function and structure of the Immune system in the developing 
an.i ma 1 as we 11 as the adu 1 t appears to be Influenced by the endocrine 
hormones, particularly growth hormone. 
Immune function normally declines with age. Immune senescence may 
be associated with or caused by age-Involution of the thymus gland. 
Growth hormone also declines with age in most animals. This decline in 
growth hormone may have an important Influence upon thymic atrophy and 
immune senescence. It was demonstrated by the research presented in 
this thesis that the administration of growth hormone to adult dogs with 
age-atrophied thymuses would cause or at least contribute to 
regeneration of the thymus. Growth hormone therapy may therefore be 
useful for restoring or Improving invnune function in aging animals. 
Immunodeficient dwarf Welmaraner puppies have been shown to be 
growth hormone deficient. The hypophyseal hormones adrenocorticotrophic 
hormone and thyroid stimulating hormone were evaluated in these puppies 
in the study presented in this thesis and found to be normal. Based on 
this evaluation, immunodeficient dwarf Weimaraner puppies appear to have 
an isolated growth hormone deficiency, although prolactin and the 
gonadotrophic hormones were not evaluated. 
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APPENDIX: INFORMATION ON THE USE OF ANIMALS IN RESEARCH AND TEACHING 
This research was conducted according to the rules and regulations 
of the Animal Welfare Act. 
